Impact of the pro12Ala polymorphism of the PPAR-gamma 2 gene on metabolic and clinical characteristics in the palestinian type 2 diabetic patients

PPAR Research

Volumn , Issue , 2009, Pages

  Nasereddin, A ^a   Ereqat, S ^a   Azmi, K ^a   Abdeen, Z ^a   Amin, R ^a  

^a AL QUDS UNIVERSITY   (Palestine)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PROLINE; TRIACYLGLYCEROL;

ADIPOCYTE; ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARAB; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; DYSLIPIDEMIA; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; OBESITY; POLYMERASE CHAIN REACTION; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TRANSCRIPTION REGULATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 72449154616     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2009/874126     Document Type: Article

References (25)

1. Freeman H., Cox R. D., Type-2 diabetes: a cocktail of genetic discovery Human Molecular Genetics 2006 15 supplement 2 R202 R209
2. Abdul-Rahim H. F., Husseini A., Giacaman R., Jervell J., Bjertness E., Diabetes mellitus in an urban Palestinian population: prevalence and associated factors Eastern Mediterranean Health Journal 2001 7 1-2 67 78 (Pubitemid 33758524)
3. He W., PPAR 2 Pro 12 Ala polymorphism and human health PPAR Research 2009 2009 15
4. Cho M.-C., Lee K., Paik S.-G., Yoon D.-Y., Peroxisome proliferators-activated receptor (PPAR) modulators and metabolic disorders PPAR Research 2008 2008 14
5. Stumvoll M., Hring H., The peroxisome proliferator-activated receptor- 2 Pro12Ala polymorphism Diabetes 2002 51 8 2341 2347
6. Deeb S. S., Fajas L., Nemoto M., A Pro12Ala substitution in PPAR 2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity Nature Genetics 1998 20 3 284 287
7. Ek J., Andersen G., Urhammer S. A., Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor- 2 (PPAR- 2) gene in relation to insulin sensitivity among glucose tolerant Caucasians Diabetologia 2001 44 9 1170 1176
8. Mori H., Ikegami H., Kawaguchi Y., The Pro 12 → Ala substitution in PPAR- is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes Diabetes 2001 50 4 891 894
9. Hara K., Okada T., Tobe K., The Pro12Ala polymorphism in PPAR 2 may confer resistance to type 2 diabetes Biochemical and Biophysical Research Communications 2000 271 1 212 216
10. Zeggini E., Parkinson J. R. C., Halford S., Examining the relationships between the Pro12Ala variant in PPARG and type 2 diabetes-related traits in UK samples Diabetic Medicine 2005 22 12 1696 1700
11. Ghoussaini M., Meyre D., Lobbens S., Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population BMC Medical Genetics 2005 6, article 11
12. Hansen S. K., Nielsen E.-M. D., Ek J., Analysis of separate and combined effects of common variation in KCNJ11 and PPARG on risk of type 2 diabetes The Journal of Clinical Endocrinology Metabolism 2005 90 6 3629 3637
13. Badii R., Bener A., Zirie M., Lack of association between the Pro 12 Ala polymorphism of the PPAR- 2 gene and type 2 diabetes mellitus in the Qatari consanguineous population Acta Diabetologica 2008 45 1 15 21
14. Bouassida K. Z., Chouchane L., Jellouli K., The peroxisome proliterator activated receptor 2 (PPAR 2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients Diabetes Metabolism 2005 31 2 119 123
15. Oh E. Y., Min K. M., Chung J. H., Significance of Pro 12 Ala mutation in peroxisome proliferator-activated receptor- 2 in Korean diabetic and obese subjects The Journal of Clinical Endocrinology Metabolism 2000 85 5 1801 1804
16. Friedewald W. T., Levy R. I., Fredrickson D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clinical Chemistry 1972 18 6 499 502
17. Johansen A., Jensen D. P., Bergholdt R., IRS1, KCNJ11, PPAR 2 and HNF-1 : do amino acid polymorphisms in these candidate genes support a shared aetiology between type 1 and type 2 diabetes? Diabetes, Obesity and Metabolism 2006 8 1 75 82
18. Tai E. S., Corella D., Deurenberg-Yap M., Differential effects of the C1431T and Pro12Ala PPAR gene variants on plasma lipids and diabetes risk in an Asian population Journal of Lipid Research 2004 45 4 674 685
19. Zietz B., Barth N., Spiegel D., Schmitz G., Schlmerich J., Schffler A., Pro12Ala polymorphism in the peroxisome proliferator-activated receptor- 2 (PPAR 2) is associated with higher levels of total cholesterol and LDL-cholesterol in male Caucasian type 2 diabetes patients Experimental and Clinical Endocrinology and Diabetes 2002 110 2 60 66
20. Ringel J., Engeli S., Distler A., Sharma A. M., Pro12Ala missense mutation of the peroxisome proliferator activated receptor and diabetes mellitus Biochemical and Biophysical Research Communications 1999 254 2 450 453
21. Thamer C., Haap M., Volk A., Evidence for greater oxidative substrate flexibility in male carriers of the Pro 12 Ala polymorphism in PPAR 2 Hormone and Metabolic Research 2002 34 3 132 136
22. DeFronzo R. A., Tobin J. D., Andres R., Glucose clamp technique: a method for quantifying insulin secretion and resistance The American Journal of Physiology 1979 237 3 E214 E223
23. Kilpelinen T. O., Lakka T. A., Laaksonen D. E., SNPs in PPARG associate with type 2 diabetes and interact with physical activity Medicine and Science in Sports Exercise 2008 40 1 25 33
24. Schneider J., Kreuzer J., Hamann A., Nawroth P. P., Dugi K. A., The Proline 12 substitution in the peroxisome proliferator-activated receptor- 2 gene is associated with lower lipoprotein lipase activity in vivo Diabetes 2002 51 3 867 870
25. Mancini F. P., Vaccaro O., Sabatino L., Pro12Ala substitution in the peroxisome proliferator-activated receptor- 2 is not associated with type 2 diabetes Diabetes 1999 48 7 1466 1468